insights_auto
Miks on ALMKT langenud? 2,70%?
Uurige põhjalikumaltchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,090 €
arrow_downward
−2,70%(−0,0025) 1 p
6. nov, 15:29:53 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ALMKT põhistatistika genereerimine…
Ava
0,08 €
Kõrge
0,09 €
Madal
0,08 €
Turu kapit.
18,06Â mln
Keskm. maht
549,48Â tuh
Maht
356,05Â tuh
Hinna ja tulu suhe
0,77
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26Â mln
Töötajate arv
56
Ava
0,08 €
Kõrge
0,09 €
Madal
0,08 €
Turu kapit.
18,06Â mln
Keskm. maht
549,48Â tuh
Maht
356,05Â tuh
Hinna ja tulu suhe
0,77
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26Â mln
Töötajate arv
56
Uudised
Veebiallikatest ja uudistepartneritelt
TradingView
·
44 minuti eest
Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
Spectrum News
·
13 minuti eest
The worldwide sell-off for AI stocks halts, but other U.S. stocks are still strugÂgling
Bloomberg.com
·
1 tunni eest
Fast-Money Systematic Funds Stoked $2.3 Trillion Tech-Stock Rout
CNN
·
4 tunni eest
What sparked the stock market’s $2.5 trillion sell-off?
Profiil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Teave üksuse Mauna Kea Technologies SA kohta
TegevjuhtSacha Loiseau
Töötajad56
Asutatud2000
Peakontorid-
SektorHealth Care
Valdkond-
Veebisaitmaunakeatech.com